Ackermans & van Haaren (ACKB) Stock Analysis: A Hidden Compounder in European Investment Holdings
 |
| Ackermans & van Haaren (ACKB) |
Worldreview1989 - Ackermans & van Haaren (Euronext Brussels: ACKB) is not a conventional industrial company. It is a diversified Belgian investment group whose value comes from a concentrated portfolio of businesses spanning marine engineering, private banking, real estate, energy and resources, and growth capital.
For American investors, ACKB is particularly interesting because it resembles a hybrid between a holding company, private-equity platform, and long-term compounder. Rather than relying on a single operating business, Ackermans & van Haaren attempts to compound shareholder value by allocating capital among a relatively small number of strategic investments.
The company reported €592.5 million of net profit in 2025, up 29% year over year, while shareholders' equity reached approximately €5.7 billion. Management subsequently reported €339.6 million of net profit in the first half of 2026, up 24%, and upgraded its outlook to expect full-year 2026 net profit growth of more than 10%.
That combination makes ACKB worth examining not simply as a Belgian stock, but as a potential European compounding vehicle.
Ackermans & van Haaren (ACKB) Stock: Quick Overview
| Metric | Latest/Relevant Figure |
|---|---|
| Company | Ackermans & van Haaren NV |
| Ticker | ACKB |
| Exchange | Euronext Brussels |
| Currency | EUR |
| 2025 Net Profit | €592.5 million |
| 2025 Net Profit Growth | +29% |
| 2025 Equity | €5.7 billion |
| 2025 Net Cash | €429 million |
| 2025 Proposed Dividend | €4.60/share |
| H1 2026 Net Profit | €339.6 million |
| H1 2026 Net Profit Growth | +24% |
| H1 2026 Net Cash | €524.4 million |
| H1 2026 Equity | €5.9 billion |
| 2026 Outlook | Net profit expected to increase >10% |
| September 9, 2026 Close | €269.60 on Euronext Brussels |
Euronext's September 9, 2026 trading data showed ACKB closing at €269.60, after trading as high as €275.40 that day. Its 52-week range reported by Euronext was approximately €208.20–€300.20.
What Is Ackermans & van Haaren?
Ackermans & van Haaren, commonly abbreviated as AvH, is an Antwerp-based investment group with a history dating back to 1876.
The company originally grew from dredging and infrastructure activities before gradually transforming itself into a diversified investment company. Following its IPO in 1984, AvH expanded into a portfolio-based model.
Today, the company operates through several major investment platforms:
Marine Engineering & Contracting
Private Banking
Real Estate
Energy & Resources
Growth Capital
AvH describes its strategy as long-term investment in a limited number of businesses with strong growth potential. The company emphasizes active ownership, strategic support, long-term capital allocation, and compounding shareholder value.
This is important because investors should not analyze ACKB like a normal industrial stock.
The central question is not simply "How much does Ackermans earn?"
The more important question is:
How efficiently does Ackermans allocate capital across its portfolio, and how much of that underlying value is reflected in the stock price?
The Portfolio Behind ACKB
1. DEME: The Industrial Growth Engine
One of the most important assets in the portfolio is DEME, a global marine engineering and construction company.
AvH owns approximately 62.12% of DEME.
DEME generated:
€4.155 billion of revenue in 2025
€346 million of net profit
€7.591 billion of order backlog
The company operates in dredging, offshore energy, marine infrastructure, environmental remediation, and related activities.
For U.S. investors, DEME is particularly interesting because its business is exposed to several structural themes:
offshore wind
marine infrastructure
energy transition
port development
subsea construction
environmental remediation
This gives ACKB indirect exposure to infrastructure spending and the global energy transition without requiring investors to buy an individual offshore engineering company.
2. Private Banking: The Cash-Flow Stabilizer
Ackermans' private banking businesses include:
Delen Private Bank
Bank Van Breda
Together, these businesses have become one of the most important contributors to AvH's earnings.
In 2025, the two private banks generated a combined €364.4 million of net profit, an increase of 11% from the previous year.
Total entrusted assets reached approximately €87.5 billion, representing 12.5% growth.
The private banking segment therefore provides ACKB with something that many industrial holding companies lack:
recurring fee-based financial earnings.
That diversification matters.
DEME can be influenced by project cycles and construction conditions, while private banking benefits from asset accumulation, investment returns, client inflows, and wealth management fees.
3. SIPEF: Exposure to Agriculture and Emerging Markets
AvH owns approximately 42.2% of SIPEF, a listed agro-industrial company primarily focused on sustainable palm oil production in Southeast Asia.
SIPEF reported:
$570 million revenue in 2025
$125 million net profit
441,867 tons of palm oil production
This provides ACKB with exposure to agricultural assets, commodity prices, tropical agriculture and Asian markets.
From a portfolio perspective, SIPEF is useful because its earnings drivers are different from those of DEME and private banking.
That is exactly what a diversified holding company should ideally accomplish.
4. CFE and Other Industrial Assets
AvH also owns approximately 62.12% of CFE, a Belgian industrial group active in construction, renovation, real estate development and multitechnics.
CFE reported:
€1.042 billion revenue in 2025
€33.5 million net profit
€1.633 billion order book
CFE gives AvH another channel into European infrastructure and construction activity.
5. Growth Capital: The Option Value
The Growth Capital portfolio is perhaps the most difficult part of ACKB to value.
According to AvH, the Growth Capital portfolio has a consolidated book value of approximately €600 million and includes roughly 20 companies with future growth potential.
This portfolio includes businesses such as:
Agidens
Biolectric
Camlin Fine Sciences
GreenStor
Mediahuis
OMP
Turbo's Hoet Groep
V. Group
Van Moer Logistics
VKC Nuts
The attraction is straightforward:
Some investments may eventually become significantly more valuable than their current book values.
The risk is equally straightforward:
Private investments are harder for public-market investors to value accurately.
This creates both potential upside and valuation uncertainty.
2025 Financial Performance
Ackermans & van Haaren had a particularly strong 2025.
Net profit
2025 net profit reached:
€592.5 million
compared with:
€459.9 million in 2024
That represents approximately:
+29% growth.
The increase was driven primarily by DEME, the private banks and SIPEF. Core segments contributed approximately €594.1 million, compared with €474.5 million in 2024.
This is an important distinction.
ACKB's earnings growth was not primarily the result of financial engineering or a one-off accounting gain.
The underlying operating portfolio generated stronger contributions.
2026: The Momentum Continued
 |
| Ackermans & van Haaren (ACKB) |
The first half of 2026 provides an even more interesting picture.
AvH reported:
€339.6 million net profit
for the first half of 2026.
That was approximately:
24% higher than H1 2025.
The company also reported:
€524.4 million net cash
and approximately:
€5.9 billion of equity.
Management upgraded its full-year outlook and now expects 2026 net profit to increase by more than 10%.
This is one of the strongest arguments for the ACKB investment case.
The earnings momentum did not stop after the exceptional 2025 performance.
Unique Analytical Component: The ACKB Portfolio Earnings Engine
A conventional stock analysis would stop at EPS, P/E and dividend yield.
For ACKB, that approach misses the most important part of the story.
I call the alternative approach the:
Portfolio Earnings Engine
Think of Ackermans as five separate earnings engines.
| Engine | Economic Role | Main Driver |
|---|---|---|
| DEME | Industrial growth | Infrastructure/offshore projects |
| Private Banking | Recurring earnings | Wealth & client assets |
| SIPEF | Commodity/agriculture exposure | Palm oil production/prices |
| CFE | Construction/infrastructure | European construction |
| Growth Capital | Option value | Private-company appreciation |
The key investment insight is that these engines are not perfectly correlated.
If offshore construction slows, private banking can still grow.
If financial markets weaken, DEME's order backlog can provide visibility.
If European construction weakens, agricultural earnings can provide another source of diversification.
This creates a potentially powerful earnings diversification effect.
The "Hidden Compounder" Test
AvH states that its equity and dividend value has achieved a compound annual growth rate of approximately 12.7% from its 1984 IPO through 2025.
That historical record is important.
A company producing 12%+ long-term compounding does not necessarily need spectacular annual earnings growth.
The real power comes from:
capital allocation + retained earnings + portfolio appreciation + dividends + reinvestment.
This is why ACKB may be more comparable conceptually to long-term holding companies than to ordinary European industrial stocks.
Valuation Analysis
At the September 9, 2026 closing price of approximately €269.60, the company had a market capitalization close to €9 billion based on its approximately 33.16 million shares outstanding. Euronext reported a market capitalization around €8.9 billion earlier in September.
Using 2025 net profit of €592.5 million, the stock's approximate trailing earnings multiple is in the mid-teens.
A simplified calculation:
€8.9 billion market capitalization ÷ €592.5 million net profit
≈ 15x earnings
This is not an obviously cheap multiple.
But ACKB should not be judged purely by P/E.
Price-to-Book Analysis
At June 30, 2026:
Equity ≈ €5.9 billion
Market capitalization ≈ €9.5 billion
That implies a rough:
Price-to-book ratio ≈ 1.6x
This is a critical valuation metric for a holding company.
Why?
Because investors are paying a premium over reported book equity for:
portfolio growth
management expertise
capital allocation
private-company upside
future earnings growth
the historical compounding record
The question therefore becomes:
Is a ~1.6x book valuation justified?
My answer is:
Potentially yes, but only if portfolio earnings continue compounding at a double-digit rate.
If earnings growth deteriorates substantially, the premium could compress.
Dividend Analysis
AvH proposed increasing its dividend to:
€4.60 per share
for the 2025 financial year, representing approximately 21% growth from the previous dividend.
At a share price of €269.60:
€4.60 ÷ €269.60 ≈ 1.7%
So ACKB is not primarily a high-yield investment.
The stock is better viewed as:
A capital appreciation and compounding investment with a growing dividend component.
This distinction is important for American investors who might otherwise compare ACKB with high-yield European financial stocks.
What American Investors May Like About ACKB
From a U.S. investor perspective, several characteristics stand out.
1. Diversification
Instead of buying five individual companies, investors obtain exposure to a portfolio controlled by one investment group.
2. Infrastructure Exposure
DEME provides exposure to marine infrastructure, offshore energy and large-scale construction projects.
3. Wealth Management
Delen Private Bank and Bank Van Breda provide exposure to recurring financial-services earnings.
4. International Revenue
The underlying portfolio operates well beyond Belgium.
5. Long-Term Capital Allocation
AvH explicitly focuses on long-term ownership rather than short-term earnings maximization.
What American Investors May Not Like
ACKB also has meaningful disadvantages.
1. European Market Access
A U.S. investor generally needs a broker that provides access to Euronext Brussels.
2. Currency Risk
An American investor's return is affected by the EUR/USD exchange rate.
A 10% gain in ACKB measured in euros does not necessarily equal a 10% gain in U.S. dollars.
3. Holding-Company Discount
The market may value ACKB below the combined value of its underlying assets.
This is common among investment holding companies.
4. Concentration
Despite having multiple businesses, the portfolio is not infinitely diversified.
DEME and the private banking businesses represent particularly important contributors.
5. Valuation Risk
At around 15x trailing earnings and roughly 1.6x book value using the above simplified calculations, ACKB is not priced like a distressed holding company.
Investors are paying for quality and future compounding.
ACKB vs. a Typical U.S. Holding Company
American investors may naturally compare ACKB with companies such as Berkshire Hathaway.
The comparison is useful—but imperfect.
| Factor | ACKB | Berkshire Hathaway |
|---|---|---|
| Geography | Europe/global | U.S./global |
| Investment style | Concentrated strategic holdings | Insurance + operating companies + investments |
| Private assets | Significant | Significant |
| Industrial exposure | High | High |
| Financial services | High | High |
| Dividend | Pays dividend | No regular dividend |
| Main market | Euronext Brussels | NYSE |
| Currency for U.S. investor | EUR | USD |
| Scale | Much smaller | Much larger |
ACKB should not be considered a European Berkshire Hathaway clone.
However, the capital-allocation model makes the comparison intellectually useful.
Investment Thesis
Bull Case
The bullish case for ACKB rests on five factors:
1. Strong earnings momentum
2025 net profit increased 29%, while H1 2026 profit increased another 24%.
2. Strong balance sheet
Net cash increased to approximately €524 million by June 2026.
3. Quality portfolio
DEME, private banking and SIPEF provide exposure to structurally different industries.
4. Long-term compounding history
AvH reports 12.7% historical CAGR for equity plus dividends since its 1984 IPO.
5. Additional optionality
Growth Capital investments could generate substantial future value if successful.
Bear Case
The bearish thesis is equally important.
1. Premium valuation
ACKB is not trading at a deep discount to its reported equity.
2. Cyclicality
DEME and CFE remain exposed to project cycles, construction conditions and capital spending.
3. Private asset opacity
Investors cannot value every Growth Capital asset with the same transparency as a publicly traded company.
4. Currency risk
U.S. investors face EUR/USD fluctuations.
5. Conglomerate discount
Even if the underlying assets perform well, the market may not fully recognize their aggregate value.
Unique Analytical Conclusion: ACKB Is a "Compounding Spread" Investment
My preferred way to think about Ackermans & van Haaren is not simply:
"Is ACKB cheap?"
Instead, ask:
"Is the company's rate of internal value creation greater than the premium investors are paying for the holding company?"
This creates what can be called the Compounding Spread.
If:
Portfolio ROE + earnings growth + successful capital allocation
consistently exceeds:
valuation premium + cost of capital + holding-company discount
then ACKB can continue creating shareholder value even when the stock does not look conventionally cheap.
This is why the 2026 earnings data are particularly important.
The company is not merely maintaining its earnings base.
It is still expanding it.
ACKB Stock: My Financial Assessment
| Category | Assessment |
|---|---|
| Business quality | Strong |
| Portfolio diversification | Strong |
| Balance sheet | Strong |
| Earnings momentum | Strong |
| Dividend growth | Positive |
| Current dividend yield | Low/Moderate |
| Valuation | Fair to moderately expensive |
| Long-term compounding potential | Strong |
| Cyclical risk | Moderate |
| Currency risk for U.S. investors | Moderate |
| Overall | Watch / Accumulate on weakness |
Which Is Right for You?
ACKB may fit investors who:
prefer long-term compounders;
want European exposure;
like diversified holding companies;
accept EUR currency risk;
value capital allocation over high dividend yield;
have a 5–10 year investment horizon.
ACKB may not fit investors who:
need high current dividend income;
want a pure-play industrial stock;
want U.S.-dollar-denominated investments;
dislike holding-company discounts;
prefer highly liquid mega-cap stocks.
Final Verdict: Is Ackermans & van Haaren (ACKB) a Good Stock?
Ackermans & van Haaren is one of the more interesting European holding-company stocks for investors seeking long-term compounding rather than immediate income.
The strongest evidence comes from the company's operating results.
Net profit increased 29% in 2025 to €592.5 million, equity reached €5.7 billion, and H1 2026 net profit increased another 24% to €339.6 million. Management has also upgraded its 2026 outlook to more than 10% net-profit growth.
The combination of DEME, private banking, SIPEF, CFE and Growth Capital creates an unusually diversified earnings structure for a Belgian-listed company.
The biggest question is valuation.
At approximately €270 per share, ACKB does not look like a bargain-bin stock. Investors are paying a premium for the quality of its portfolio and its historical capital-allocation record.
For that reason, I would classify ACKB as:
A High-Quality European Compounder — Attractive for Long-Term Investors, More Attractive on Meaningful Pullbacks
The key metric to monitor is not simply the next quarter's EPS.
Investors should track:
growth in equity per share + dividends + portfolio earnings + net cash + changes in the discount/premium to underlying asset value.
That combination provides a much better picture of ACKB's intrinsic shareholder value than P/E alone.
Risk Disclaimer
This article is for informational and educational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a guarantee of future returns.
Investors should independently review Ackermans & van Haaren's financial statements, portfolio-company results, valuation, currency exposure, taxation, trading liquidity and their own investment objectives before making an investment decision.
Past performance and historical compounding do not guarantee future returns.
Primary Sources & Further Reading
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks
Join Facebook Group